By Ursula Hirschkorn (European Pharmaceutical Review)2026-08-04T13:34:00
Growing demand for real-time process monitoring and more consistent biopharmaceutical manufacturing is expected to drive investment in process analytical technology.
The global biopharmaceutical process analytical technology (PAT) market is forecast to reach $4.32 billion by 2031, according to a market report published by MarketsandMarkets on 28 July.
The commercial market forecast points to increasing adoption of analytical systems that allow manufacturers to measure and control production processes as they take place…
Already a member? Sign-in
European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-19T09:05:00Z
Sponsored by PCI Pharma Services
2026-10-19T13:13:00Z
2026-10-19T10:02:00Z
Sponsored by Cytiva
2026-06-15T07:55:00
Sponsored by Octave, By Adam Cross
2026-08-25T08:09:00
Sponsored by LabVantage
2027-01-27T15:00:00
Sponsored by Cell Signaling Technology
2026-08-03T08:39:00
Sponsored by Shimadzu
2026-06-16T13:00:00
Sponsored by USP
Site powered by Webvision Cloud